image credit: Unsplash

IPM announces WHO’s prequalification of dapivirine ring to reduce women’s HIV risk

November 30, 2020


The nonprofit International Partnership for Microbicides (IPM) is pleased to announce the World Health Organization’s (WHO) prequalification of the dapivirine ring, a monthly vaginal ring to reduce women’s HIV risk.

This designation from the WHO confirms that the ring meets global standards for quality, safety and efficacy. The product’s addition to the WHO’s list of prequalified medicines will help guide national and global procurement decisions, pending country regulatory approvals for its use. The ring’s prequalification follows a positive scientific opinion for the product in July 2020 from the European Medicines Agency (EMA) under Article 58.

Read More on The Medical News